Roche
Roche Pharmaceuticals in the U.S.
Home About Us Roche & Community R&D Products Programs & Services Careers Newsroom
Search | Site Map | Contact
Search Site Map Contact
Roche Pharmaceuticals in the U.S. Virtual Newsroom

2009 Press Releases
 
Search the releases for: Press Release Archive:
2009  2008  2007 
June 2009
 
06-26-2009 ROCHE DISCONTINUES AND PLANS TO DELIST ACCUTANE IN THE U.S.
 
06-09-2009 ROCHE TO COMMENCE PHASE III TRIALS WITH INNOVATIVE TREATMENT DESIGNED TO LOWER CARDIOVASCULAR RISK IN DIABETES PATIENTS WITH RECENT HEART ATTACK
 
06-09-2009 DATA DEMONSTRATED ACTEMRA® (TOCILIZUMAB) SIGNIFICANTLY INHIBITED PROGRESSION OF STRUCTURAL JOINT DAMAGE IN RHEUMATOID ARTHRITIS PATIENTS
 
06-08-2009 ROCHE SYMPOSIUM SHOWCASES ACCOMPLISHMENTS OF NEXT GENERATION OF CHEMISTS
 
06-04-2009 ACTEMRA® (TOCILIZUMAB) STUDIES TO BE FEATURED AT THE EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) CONGRESS
 
06-01-2009 IMPACT STUDY SHOWED LONGER VALCYTE® (VALGANCICLOVIR HYDROCHLORIDE TABLETS) TREATMENT DEMONSTRATED BETTER PROTECTION AGAINST CYTOMEGALOVIRUS (CMV) DISEASE ONE YEAR POST-TRANSPLANT
 
May 2009
 
05-25-2009 TWO-YEAR DATA REINFORCE EFFECT OF ACTEMRA® (TOCILIZUMAB) IN INHIBITING PROGRESSION OF JOINT DAMAGE AND IMPROVING PHYSICAL FUNCTION IN RHEUMATOID ARTHRITIS PATIENTS
 
05-11-2009 ROCHE’S PIERSON HONORED AS 2009 HBA RISING STAR
 
05-01-2009 ROCHE WOMEN HONORED AS 2009 TWIN AWARDEES
 
April 2009
 
04-25-2009 GROUND-BREAKING COMBINATION OF ALL-ORAL AGENTS DEMONSTRATES POTENTIAL AS HEPATITIS C TREATMENT REGIMEN
 
04-23-2009 ROCHE MADISON MOVES TO NEW FACILITY
 
 
 
 


"THIS SITE INTENDED FOR U.S. AUDIENCES ONLY"
Copyright © 2002- Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement.